Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib is a research paper published in Oncotarget (2021). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA244845
National Institutes of Health
Grant: 5R21CA170035-02
Integrating plasma IGF-1 into novel classification of hepatocellular carcinoma
National Institutes of Health
Grant: 5K07CA106458-05
Molecular Epidemiology of Chronic Liver Diseases
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 5R21CA190945-02
Novel Point-of-Care Tool to Predict Response to Sorafenib in Hepatocellular Carcinoma
National Institutes of Health
Grant: 1R01CA151533-01A1
Role of IGF-IR tyrosine kinase in NPM-ALK-expressing T-cell lymphoma
Fields of Study
Keywords
Sustainable Development Goals